Association of follicle‐stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Lin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bo…. Hauptthemen laut MEDLINE: Bone Density, Follicle Stimulating Hormone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Health of the People's Republic of China.
Abstract (Originalsprache)
Background
Elevated follicle‐stimulating hormone (FSH) is associated with an increased risk of postmenopausal osteoporosis. This study investigated the association of serum FSH with bone turnover markers (BTMs) and bone mineral density (BMD) in healthy women undergoing menopausal transition.
Methods
A total of 487 healthy women (age 35–65 years, 50 ± 8.5 years) were enrolled in this study. Serum FSH, BTMs, and BMD at lumbar spine and total hip were measured in these subjects.
Results
Follicle‐stimulating hormone was positively correlated with various BTMs ( r = 0.339–0.583, all p < 0.001) and negatively correlated with lumbar spine and total hip BMD ( r = −0.629 and −0.514, all p < 0.001). After adjusting for age and body mass index, the partial correlation coefficients of FSH with BTMs and BMD remained significant. Estimating from the regression equation, for every 10 IU/L increase in serum FSH, BTMs increased by 0.38–3.6 units, and BMD decreased by 0.03–0.05 g/cm 2 , respectively. Multiple linear regression analysis showed that FSH was a positive factor for serum bone‐specific alkaline phosphatase, osteocalcin, and N‐telopeptide of collagen type 1 ( β = 0.188–0.403, all p < 0.001), and a negative factor for lumbar spine BMD and serum C‐telopeptide of collagen type 1 ( β = −0.629 and –0.183, all p < 0.001).
Conclusions
This study suggests that serum FSH levels are an independent risk factor for BTMs and BMD in menopause‐transitioning women, particularly for serum BAP and lumbar spine BMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, The Second Xiangya Hospital of Central South University,…
- Department of Endocrinology and Metabolism, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
ORCID-Profile: Xi-Yu Wu
Förderung
- National Natural Science Foundation of China
- Ministry of Health of the People's Republic of China
Zitieren
APA
Li, L., Pi, Y. Z., Zhang, H., Dai, R. C., Yuan, L. Q., Sheng, Z. F., & Wu, X. Y. (2023). Association of follicle‐stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24899
Vancouver
Li L, Pi YZ, Zhang H, Dai RC, Yuan LQ, Sheng ZF, et al. Association of follicle‐stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24899
BibTeX
@article{Li2023,
author = {Li, Lin and Pi, Yin-Zhen and Zhang, Hong and Dai, Ru-Chun and Yuan, Ling-Qing and Sheng, Zhi-Feng and Wu, Xi-Yu},
title = {Association of follicle‐stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24899}
}
EUVIMED